3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
Abstract Treatment with statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase, has proven beneficial preventive effects on cardiovascular events. However …
reductase, has proven beneficial preventive effects on cardiovascular events. However …
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2024
Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Classification of diabetes using multilayer perceptron
SS Sivasankari, J Surendiran, N Yuvaraj… - 2022 IEEE …, 2022 - ieeexplore.ieee.org
The breakthroughs in public healthcare infrastructure have resulted in a large influx of highly
sensitive and critical healthcare information. The application of sophisticated data analysis …
sensitive and critical healthcare information. The application of sophisticated data analysis …
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025.
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Statins and risk of type 2 diabetes: mechanism and clinical implications
M Laakso, L Fernandes Silva - Frontiers in Endocrinology, 2023 - frontiersin.org
Statins are widely used to prevent cardiovascular disease events. Cardiovascular diseases
and type 2 diabetes are tightly connected since type 2 diabetes is a major risk factor for …
and type 2 diabetes are tightly connected since type 2 diabetes is a major risk factor for …
Consumption of ultra-processed foods and all-cause and cause-specific mortality in the Southern Community Cohort Study
Background & aims Higher intake of ultra-processed foods (UPF) has been linked with
higher risks of cancer, cardiovascular disease, and diabetes, as well as all-cause mortality …
higher risks of cancer, cardiovascular disease, and diabetes, as well as all-cause mortality …
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
WE Corpeleijn, WJ de Waal, HS Schipper, A Wiegman - Diabetologia, 2024 - Springer
In the last few decades, atherosclerotic cardiovascular disease (ASCVD) risk has decreased
dramatically among individuals affected by familial hypercholesterolaemia (FH) as a result of …
dramatically among individuals affected by familial hypercholesterolaemia (FH) as a result of …
Integrated multicomponent interventions to support healthy aging of the whole person
HM Langevin, W Weber, W Chen - Aging Cell, 2024 - Wiley Online Library
Healthy aging is an integrated “whole person” process that involves an individual's biology,
behavior, and social/physical environment. With the recent development of antiaging drugs …
behavior, and social/physical environment. With the recent development of antiaging drugs …
Treatment with proprotein convertase Subtilisin/Kexin type 9 inhibitors (PCSK9i): current evidence for expanding the paradigm?
RV Giglio, EM Muzurović, AM Patti… - Journal of …, 2023 - journals.sagepub.com
Background: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are low-
density lipoprotein cholesterol (LDL-C)-lowering drugs that play a critical role in lipoprotein …
density lipoprotein cholesterol (LDL-C)-lowering drugs that play a critical role in lipoprotein …